---
title: "Bristol-Myers Squibb (BMY) Receives a Buy from Piper Sandler"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/288271043.md"
description: "Piper Sandler analyst David Amsellem reiterated a Buy rating on Bristol-Myers Squibb (BMY) with a $75 price target. This follows a recent Buy from UBS, while Citi maintained a Hold rating on the stock."
datetime: "2026-06-01T12:04:05.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/288271043.md)
  - [en](https://longbridge.com/en/news/288271043.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/288271043.md)
---

# Bristol-Myers Squibb (BMY) Receives a Buy from Piper Sandler

In a report released today, David Amsellem from Piper Sandler reiterated a Buy rating on Bristol-Myers Squibb, with a price target of $75.00.

### Claim 55% Off TipRanks

-   Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst ratings and forecasts to breaking news and portfolio analysis.
-   Discover high-conviction stock picks and new investing opportunities with the TipRanks Smart Investor Newsletter

Amsellem covers the Healthcare sector, focusing on stocks such as Amgen, Teva Pharmaceutical, and AbbVie. According to TipRanks, Amsellem has an average return of 11.7% and a 57.52% success rate on recommended stocks.

In addition to Piper Sandler, Bristol-Myers Squibb also received a Buy from UBS’s Michael Yee in a report issued on May 28. However, yesterday, Citi maintained a Hold rating on Bristol-Myers Squibb (NYSE: BMY).

### Related Stocks

- [BMY.US](https://longbridge.com/en/quote/BMY.US.md)
- [PIPR.US](https://longbridge.com/en/quote/PIPR.US.md)
- [AMGN.US](https://longbridge.com/en/quote/AMGN.US.md)
- [TEVA.US](https://longbridge.com/en/quote/TEVA.US.md)
- [ABBV.US](https://longbridge.com/en/quote/ABBV.US.md)
- [UBS.US](https://longbridge.com/en/quote/UBS.US.md)
- [C.US](https://longbridge.com/en/quote/C.US.md)
- [CELG.RT.US](https://longbridge.com/en/quote/CELG.RT.US.md)
- [C-R.US](https://longbridge.com/en/quote/C-R.US.md)

## Related News & Research

- [Bristol-Myers Squibb Co Stock (BMY) Closed Down by 3.00% on Jun 8: A Full Analysis](https://longbridge.com/en/news/289202504.md)
- [Bristol Myers Squibb Target of Unusually High Options Trading (NYSE:BMY)](https://longbridge.com/en/news/288476616.md)
- [Billionaire Izzy Englander Just Made a Big Bet on This Beaten-Down High-Yield Dividend Stock](https://longbridge.com/en/news/288895535.md)
- [FACTBOX-Major deals involving US drugmakers and biotechs over the past decade](https://longbridge.com/en/news/289163903.md)
- [waypoint wealth counsel Buys Shares of 22,134 Bristol Myers Squibb Company $BMY](https://longbridge.com/en/news/283847222.md)